Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3031)
All Articles published online
|
Mar 28, 2005 (publication date) through Jan 2, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kraus MR, Schäfer A, Csef H, Scheurlen M. Psychiatric side effects of pegylated interferon alfa-2b as compared to conventional interferon alfa-2b in patients with chronic hepatitis C. World J Gastroenterol 2005; 11(12): 1769-1774 [PMID: 15793861 DOI: 10.3748/wjg.v11.i12.1769] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i12/1769.htm |
| Number | Citing Articles |
| 1 |
Shiva Khayatimotlagh, Elham Ebrahimi, Seyed Moayed Alavian, Maryam Hassani, Masud Yunesian, Afsaneh Keramat, Marjan Hassani, Nahid Bolbolhaghighi. Designing and Psychometric Evaluation of a Questionnaire for Health Needs of Hepatitis B Affected Women: A Mixed Method Study in Reproductive Health Domain. Iranian Red Crescent Medical Journal 2020; 22(2) doi: 10.5812/ircmj.99414
|
| 2 |
Th. Till Wissniowski, Marion Ganslmayer, Steffen Zopf, Eckhart G. Hahn, Christoph Herold. Antivirale Therapie bei chronischer Hepatitis C. Psychosomatik und Konsiliarpsychiatrie 2007; 1(2): 158 doi: 10.1007/s11800-007-0031-y
|
| 3 |
Martin Schaefer, Lucile Capuron, Astrid Friebe, Crisanto Diez-Quevedo, Geert Robaeys, Sergio Neri, Graham R. Foster, Achim Kautz, Daniel Forton, Carmine M. Pariante. Hepatitis C infection, antiviral treatment and mental health: A European expert consensus statement. Journal of Hepatology 2012; 57(6): 1379 doi: 10.1016/j.jhep.2012.07.037
|
| 4 |
Alfredo Alberti. What are the comorbidities influencing the management of patients and the response to therapy in chronic hepatitis C?. Liver International 2009; 29(s1): 15 doi: 10.1111/j.1478-3231.2008.01945.x
|
| 5 |
Ali HassanpourDehkordi, Nooredin Mohammadi, Alireza NikbakhatNasrabadi. Hepatitis-related stigma in chronic patients: A qualitative study. Applied Nursing Research 2016; 29: 206 doi: 10.1016/j.apnr.2015.04.010
|
| 6 |
Adrian W. Dollarhide, Catherine Loh, Susan G. Leckband, Rene Endow-Eyer, Shannon Robinson, Jonathan M. Meyer. Psychiatric Comorbidity Does Not Predict Interferon Treatment Completion Rates in Hepatitis C Seropositive Veterans. Journal of Clinical Gastroenterology 2007; 41(3): 322 doi: 10.1097/01.mcg.0000225629.22286.96
|
| 7 |
Amy A. Dan, Cathy Crone, Thomas N. Wise, Lisa M. Martin, Lolita Ramsey, Scarlett Magee, Robert Sjogren, Janus P. Ong, Zobair M. Younossi. Anger Experiences Among Hepatitis C Patients: Relationship to Depressive Symptoms and Health-Related Quality of Life. Psychosomatics 2007; 48(3): 223 doi: 10.1176/appi.psy.48.3.223
|
| 8 |
Pharmacological agents can ameliorate some of the neuropsychiatric adverse effects of interferon-?? treatment. Drugs & Therapy Perspectives 2005; 21(11): 18 doi: 10.2165/00042310-200521110-00007
|
| 9 |
Hymie Anisman, Kim Matheson, Shawn Hayley. Risk Factors in Depression. 2008; : 63 doi: 10.1016/B978-0-08-045078-0.00004-6
|
| 10 |
E.C.M. Cunha, M.F. Behrensdorf, V. Bavaresco, D.N. Zambrano, J. Bellini, M.P. Kaster, B. Spessato, G. Ghisleni. Genotype 1 of hepatitis C virus increases the risk of major depression: a 12-week prospective study. General Hospital Psychiatry 2015; 37(4): 283 doi: 10.1016/j.genhosppsych.2015.03.016
|
| 11 |
Nikroo Hashemi, Simona Rossi, Victor J Navarro, Steven K Herrine. Safety of peginterferon in the treatment of chronic hepatitis C. Expert Opinion on Drug Safety 2008; 7(6): 771 doi: 10.1517/14740330802423291
|
| 12 |
C. O'Brien. Issues in designing and interpreting clinical trials of treatments for chronic hepatitis C. Journal of Viral Hepatitis 2006; 13(s1): 6 doi: 10.1111/j.1365-2893.2006.00757.x
|
| 13 |
Hans-Peter Kapfhammer. Depression, Angst, traumatischer Stress und internistische Erkrankungen. 2022; : 475 doi: 10.1007/978-3-662-65873-4_7
|
| 14 |
Alasdair Timothy Llewelyn Rathbone, Surejini Tharmaradinam, Shucui Jiang, Michel P. Rathbone, Dinesh A. Kumbhare. A review of the neuro- and systemic inflammatory responses in post concussion symptoms: Introduction of the “post-inflammatory brain syndrome” PIBS. Brain, Behavior, and Immunity 2015; 46: 1 doi: 10.1016/j.bbi.2015.02.009
|
| 15 |
Jessa Koch, Sarah Ward, Bobbie Martin, Christopher Thomas. A review of suicidality in nonpsychotropic medications. Mental Health Clinician 2015; 5(5): 224 doi: 10.9740/mhc.2015.09.224
|
| 16 |
Jun Wang, Jennifer Blaze, Fatemeh Haghighi, Seunghee Kim-Schulze, Urdvha Raval, Kyle J. Trageser, Giulio Maria Pasinetti. Characterization of 3(3,4-dihydroxy-phenyl) propionic acid as a novel microbiome-derived epigenetic modifier in attenuation of immune inflammatory response in human monocytes. Molecular Immunology 2020; 125: 172 doi: 10.1016/j.molimm.2020.07.003
|
| 17 |
Brian A. Baldo. Side Effects of Cytokines Approved for Therapy. Drug Safety 2014; 37(11): 921 doi: 10.1007/s40264-014-0226-z
|
| 18 |
Tomasz Pawelczyk, Agnieszka Pawelczyk, Dominik Strzelecki, Jolanta Rabe-Jablonska. Pegylated interferon α and ribavirin therapy may induce working memory disturbances in chronic hepatitis C patients. General Hospital Psychiatry 2008; 30(6): 501 doi: 10.1016/j.genhosppsych.2008.03.001
|
| 19 |
Peter L. Franzen, Daniel J. Buysse, Mordechai Rabinovitz, Bruce G. Pollock, Francis E. Lotrich. Poor sleep quality predicts onset of either major depression or subsyndromal depression with irritability during interferon-alpha treatment. Psychiatry Research 2010; 177(1-2): 240 doi: 10.1016/j.psychres.2009.02.011
|
| 20 |
Leila Valizadeh, Vahid Zamanzadeh, Reza Negarandeh, Farhad Zamani, Angela Hamidia, Ali Zabihi. Psychological Reactions among Patients with Chronic Hepatitis B: a Qualitative Study. Journal of Caring Sciences 2016; 5(1): 57 doi: 10.15171/jcs.2016.006
|
| 21 |
Michael R. Kraus, Oliver Al-Taie, Arne Schäfer, Matthias Pfersdorff, Klaus–Peter Lesch, Michael Scheurlen. Serotonin-1A Receptor Gene HTR1A Variation Predicts Interferon-Induced Depression in Chronic Hepatitis C. Gastroenterology 2007; 132(4): 1279 doi: 10.1053/j.gastro.2007.02.053
|
| 22 |
Thomas Wobrock, Ulrike Mihm, Caroline Löhr, Wolf-Peter Hofmann, Christoph Sarrazin, Stefan Zeuzem, Peter Falkai. Cognition in hepatitis C patients treated with pegylated interferon. The World Journal of Biological Psychiatry 2009; 10(4-3): 819 doi: 10.1080/15622970701714362
|
| 23 |
Ferdinando Fusco, Gianluca D'Anzeo, Andrea Rossi, Carmine Sciorio, Antonio Riccardo Buonomo, Roberta d'Emmanuele di Villa Bianca, Guglielmo Borgia, Vincenzo Mirone, Ivan Gentile. Erectile dysfunction in patients with chronic viral hepatitis: a systematic review of the literature. Expert Opinion on Pharmacotherapy 2013; 14(18): 2533 doi: 10.1517/14656566.2013.850073
|
| 24 |
Rosa Quelhas, Alice Lopes. Psychiatric Problems in Patients Infected with Hepatitis C Before and During Antiviral Treatment with Interferon-Alpha: A Review. Journal of Psychiatric Practice 2009; 15(4): 262 doi: 10.1097/01.pra.0000358313.06858.ea
|
| 25 |
M. Bourliere. Traitement de l’hépatite C : gestion des effets secondaires. Gastroentérologie Clinique et Biologique 2008; 32(5): S166 doi: 10.1016/j.gcb.2008.04.019
|
| 26 |
Marjolein Bannink, Wim H.J. Kruit, Arthur R. Van Gool, Stefan Sleijfer, Bronno van der Holt, Alexander M.M. Eggermont, Gerrit Stoter, Michiel W. Hengeveld. Interferon-α in Oncology Patients: Fewer Psychiatric Side Effects Than Anticipated. Psychosomatics 2008; 49(1): 56 doi: 10.1176/appi.psy.49.1.56
|
| 27 |
Patrick Marcellin, Stuart K Roberts, K Rajender Reddy, Stephen A Harrison, Donald M Jensen, Stephanos Hadziyannis, Moises Diago, Martin Weltman, Diethelm Messinger, Fernando Tatsch, Mario Rizzetto. Safety profile of standard- vs. high-dose peginterferon alfa-2a plus standard-dose ribavirin in HCV genotype 1/4 patients: pooled analysis from 5 randomized studies. Expert Opinion on Drug Safety 2012; 11(6): 901 doi: 10.1517/14740338.2012.721927
|
| 28 |
R.J. Andrade. Manejo de los efectos adversos del tratamiento. Gastroenterología y Hepatología 2006; 29: 184 doi: 10.1157/13097657
|
| 29 |
Elif Doyuk Kartal, Saygin Nayman Alpat, Ilhan Ozgunes, Gaye Usluer. Adverse effects of high-dose interferon-α-2a treatment for chronic hepatitis B. Advances in Therapy 2007; 24(5): 963 doi: 10.1007/BF02877700
|
| 30 |
W. L. GIANOTTEN, L. HEIJNEN. Haemophilia, aging and sexuality. Haemophilia 2009; 15(1): 55 doi: 10.1111/j.1365-2516.2008.01914.x
|
| 31 |
F. SCHMIDT, G. JANSSEN, G. MARTIN, R. LORENZ, K. LOESCHKE, M. SOYKA, C. FOLWACZNY, M. SCHAEFER. Factors influencing long‐term changes in mental health after interferon‐alpha treatment of chronic hepatitis C. Alimentary Pharmacology & Therapeutics 2009; 30(10): 1049 doi: 10.1111/j.1365-2036.2009.04123.x
|
| 32 |
Gregory M. Asnis, Richard De La Garza. Interferon-Induced Depression in Chronic Hepatitis C: A Review of Its Prevalence, Risk Factors, Biology, and Treatment Approaches. Journal of Clinical Gastroenterology 2006; 40(4): 322 doi: 10.1097/01.mcg.0000210099.36500.fe
|
| 33 |
Andrew Robert Beckwith. The Precipitation of Mania by Citalopram in a Patient With Interferon-Induced Depression. Psychosomatics 2008; 49(4): 362 doi: 10.1176/appi.psy.49.4.362-a
|
| 34 |
Hai–Yin Jiang, Min Deng, Yong–Hua Zhang, Hua–Zhong Chen, Qian Chen, Bing Ruan. Specific Serotonin Reuptake Inhibitors Prevent Interferon-α–Induced Depression in Patients With Hepatitis C: A Meta-analysis. Clinical Gastroenterology and Hepatology 2014; 12(9): 1452 doi: 10.1016/j.cgh.2013.04.035
|
| 35 |
Francis E. Lotrich, Barry Sears, Robert K. McNamara. Anger induced by interferon-alpha is moderated by ratio of arachidonic acid to omega-3 fatty acids. Journal of Psychosomatic Research 2013; 75(5): 475 doi: 10.1016/j.jpsychores.2013.07.012
|
| 36 |
Leila Valizadeh, Vahid Zamanzadeh, Ali Zabihi, Reza Negarandeh, Seyedeh Roghayeh Jafarian Amiri. Qualitative study on the experiences of hepatitis B carriers in coping with the disease. Japan Journal of Nursing Science 2019; 16(2): 194 doi: 10.1111/jjns.12229
|
| 37 |
R. MARTÍN‐SANTOS, C. DÍEZ‐QUEVEDO, P. CASTELLVÍ, R. NAVINÉS, M. MIQUEL, H. MASNOU, A. SOLER, M. ARDEVOL, F. GARCÍA, J. A. GALERAS, R. PLANAS, R. SOLÀ. De novo depression and anxiety disorders and influence on adherence during peginterferon‐alpha‐2a and ribavirin treatment in patients with hepatitis C. Alimentary Pharmacology & Therapeutics 2008; 27(3): 257 doi: 10.1111/j.1365-2036.2007.03568.x
|
| 38 |
Stanislas Pol, Marc Bourlière. Optimizing Treatment Outcomes in Chronic Hepatitis C: Management of Non-Response. Antiviral Therapy 2006; 11(8): 955 doi: 10.1177/135965350601100815
|
| 39 |
Benjamin J. Morasco, Muhamad Aly Rifai, Jennifer M. Loftis, David W. Indest, James Kelly Moles, Peter Hauser. A randomized trial of paroxetine to prevent interferon-α-induced depression in patients with hepatitis C. Journal of Affective Disorders 2007; 103(1-3): 83 doi: 10.1016/j.jad.2007.01.007
|
| 40 |
Arne Schäfer, Hans‐Ulrich Wittchen, Markus Backmund, Michael Soyka, Jörg Gölz, Jens Siegert, Martin Schäfer, Felix Tretter, Michael R. Kraus. Psychopathological changes and quality of life in hepatitis C virus‐infected, opioid‐dependent patients during maintenance therapy. Addiction 2009; 104(4): 630 doi: 10.1111/j.1360-0443.2009.02509.x
|
| 41 |
Francis E. Lotrich, Robert E. Ferrell, Mordechai Rabinovitz, Bruce G. Pollock. Labile Anger During Interferon Alfa Treatment is Associated With a Polymorphism in Tumor Necrosis Factor α. Clinical Neuropharmacology 2010; 33(4): 191 doi: 10.1097/WNF.0b013e3181de8966
|
| 42 |
Chae Sung Lee, Yogesh Kulkarni, Vicki Pierre, Manish Maski, Christoph Wanner. Adverse Impacts of PEGylated Protein Therapeutics: A Targeted Literature Review. BioDrugs 2024; 38(6): 795 doi: 10.1007/s40259-024-00684-z
|
| 43 |
Karen F. Murray, James R. Rodrigue, Regino P. González-Peralta, John Shepherd, Bruce A. Barton, Patricia R. Robuck, Kathleen B. Schwarz. Design of the PEDS-C trial: pegylated interferon +/- ribavirin for children with chronic hepatitis C viral infection. Clinical Trials 2007; 4(6): 661 doi: 10.1177/1740774507085445
|
| 44 |
Francis E. Lotrich. Inflammatory cytokine-associated depression. Brain Research 2015; 1617: 113 doi: 10.1016/j.brainres.2014.06.032
|
| 45 |
C L Raison, A H Miller. The evolutionary significance of depression in Pathogen Host Defense (PATHOS-D). Molecular Psychiatry 2013; 18(1): 15 doi: 10.1038/mp.2012.2
|
| 46 |
Arne Schäfer, Hans‐Ulrich Wittchen, Jochen Seufert, Michael R. Kraus. Methodological approaches in the assessment of interferon‐alfa‐induced depression in patients with chronic hepatitis C – a critical review. International Journal of Methods in Psychiatric Research 2007; 16(4): 186 doi: 10.1002/mpr.229
|
| 47 |
Muhamad Aly Rifai, David Indest, Jennifer Loftis, Peter Hauser. Psychiatric management of the hepatitis C patient. Current Treatment Options in Gastroenterology 2006; 9(6): 508 doi: 10.1007/s11938-006-0007-6
|